PCCTC Trial Results: Neoadjuvant Enzalutamide Prior to Prostatectomy

Press Releases by admin May 9, 2017

Study led by the University of Washington published in Clinical Cancer Research provides evidence of continued androgen receptor (AR) activity in residual tumor suggesting AR signaling may contribute to survival.